GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 8 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE265788_IDH1 inhibition_RNA-Directed DNA Polymerase_7_v_8_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE265788_IDH1 inhibition_RNA-Directed DNA Polymerase_7_v_8_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE265788_IDH1 inhibition_RNA-Directed DNA Polymerase_7_v_8_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE265788_IDH1 inhibition_RNA-Directed DNA Polymerase_7_v_8_human_up.

Results found

Linked to

 

Label

Description

 

Gene

carbonic anhydrase 2

Gene

MAGE family member A3

Gene

clusterin

Gene

MAGE family member A6

Gene

insulin like growth factor binding protein 2

Gene

tissue factor pathway inhibitor

Gene

SRY-box transcription factor 9

Gene

glutamate-ammonia ligase

Gene

cell adhesion molecule 1

Gene

Fc gamma binding protein

  • Gene

    carbonic anhydrase 2


  • Gene

    MAGE family member A3



  • Gene

    MAGE family member A6


  • Gene

    insulin like growth factor binding protein 2


  • Gene

    tissue factor pathway inhibitor


  • Gene

    SRY-box transcription factor 9


  • Gene

    glutamate-ammonia ligase


  • Gene

    cell adhesion molecule 1


  • Gene

    Fc gamma binding protein

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.